Related Experiment Videos
Unexplained bleeding associated with central venous catheter care
S K Morgan1, O C Grush, D Jernigan
1Department of Pediatrics, Medical University of South Carolina, Charleston 29425.
The American Journal of Pediatric Hematology/Oncology
|January 1, 1989
Summary
Children with cancer and central venous catheters may experience severe bleeding from accidental heparin overdose. Proper catheter maintenance and anticoagulation techniques are crucial to prevent this serious complication.
Area of Science:
- Pediatric Oncology
- Hematology
- Vascular Access Devices
Background:
- Indwelling central venous catheters (CVCs) are essential for chemotherapy delivery in pediatric cancer patients.
- Heparin is commonly used for CVC maintenance and anticoagulation, but carries a risk of bleeding.
- Overdosage can lead to significant hemorrhage, complicating patient management.
Observation:
- A case of a child with Wilms' tumor presented with unexplained significant bleeding.
- The bleeding was ultimately attributed to inadvertent heparin overdosage related to CVC management.
- The etiology of bleeding in this context may not be immediately obvious.
Findings:
- Inadvertent heparin overdosage is a critical risk factor for severe bleeding in pediatric cancer patients with CVCs.
- The bleeding complications can be severe and may not have an apparent initial cause.
- This highlights the importance of precise heparin dosing and administration.
Implications:
- Strict adherence to recommended heparinization protocols for CVCs is imperative in pediatric oncology.
- Healthcare providers must be vigilant in monitoring for and investigating bleeding in these high-risk patients.
- Improved education and standardized procedures for CVC care can mitigate bleeding risks.